serum institute of india news
Latest from serum institute of india
Cervical cancer prevention: Not many takers for HPV vaccine at Chandigarh’s PGIMER
Cervavac was developed by Serum Institute Of India (SII) in collaboration with central government’s department of biotechnology (DBT) and the Biotechnology Industry Research Assistance Council (BIRAC), along with the Bill and Melinda Gates Foundation
Published on Apr 16, 2025 10:36 AM IST
Priyanka Thakur, Chandigarh
Adar Poonawalla speaks out on work-life balance: 'Can't go beyond 8-9 hours'
The Serum CEO said that meeting people and building relationships, for charity or networking purposes, is as crucial as office hours.
Updated on Jan 23, 2025 12:43 PM IST
Ajit Pawar visits SPPU, takes review of various works
The deputy chief minister said that not a single university in the country is in the list of top 200 universities in the world. He assured that the state government will provide support to the university to get its name in the global list
Updated on Jan 10, 2025 08:12 AM IST
Health Talk: Why an India-made Chikungunya vaccine is good news
Serum Institute of India will manufacture Valneva's anti-Chikungunya vaccine for India and select Asian markets, addressing a major public health issue.
Updated on Dec 21, 2024 01:18 PM IST
SII to manufacture French firm’s vaccine for chikungunya
Serum Institute of India will manufacture a chikungunya vaccine for the Indian market and a few other Asian countries under a licensing agreement between the company and France-based Valneva SE’s
Updated on Dec 20, 2024 07:10 AM IST
Rhythma Kaul, New Delhi
Serum Institute of India to manufacture French company Valneva’s Chikungunya vaccine
According to government data, 11,477 cases of chikunguny were reported last year, and so far, 12,587 confirmed cases have been reported this year
Updated on Dec 19, 2024 07:51 PM IST
Serum Institute to manufacture Mpox vaccine by Danish maker Bavarian Nordic
India reported the first case of mpox disease caused by the “clade 1b” strain that prompted WHO to declare the infection a global health emergency in September this year, which was the second case of the viral disease so far this year
Published on Dec 16, 2024 08:54 PM IST
Meet Cyrus Poonawalla, Pune's richest man with a net worth of ₹2,04,300 crore
The ninth richest billionaire in the country, Poonawalla boasts a home worth ₹750 crore
Published on Oct 27, 2024 12:18 PM IST
Adar Poonawala on buying stake in Dharma productions: ‘My friend Karan Johar...’
Adar Poonawalla is acquiring a 50% stake in Karan Johar's Dharma Productions for 1000 crore, allowing Johar to maintain creative control.
Updated on Oct 21, 2024 01:53 PM IST
SII to develop Mpox vaccine within a year
Serum Institute of India (SII) Pune on Tuesday said it is currently working to develop a vaccine for Mpox with positive outcomes expected in a year’s time
Updated on Aug 21, 2024 08:00 AM IST
Vicky Pathare
Pune’s Serum Institute ships malaria vaccine to African countries
Serum Institute of India ships R21/Matrix-M™ malaria vaccine to Africa, starting with Central African Republic. 163,800 doses allocated for CAR.
Updated on May 21, 2024 07:36 AM IST
Vicky Pathare
SII to acquire 20% stake in needle-free tech firm IntegriMedical
Vaccine major SII on Friday announced to acquire 20 per cent stake in medical device company IntegriMedical to advance in needle-free injection system technology
Updated on May 18, 2024 08:18 AM IST
All Covishield side-effects were disclosed: Serum Institute of India
Emphasizing safety as a priority, the company also highlighted Covishield’s role in saving millions of lives globally.
Updated on May 09, 2024 04:10 AM IST
Vicky Pathare
Parents sue Serum Institute over daughter's death, allegedly due to Covishield
Covishield is the Indian variant of AstraZeneca's Covid-19 vaccine. AstraZeneca recently admitted that its vaccine can cause a rare side-effect called ‘TTS.’
Published on May 02, 2024 11:19 AM IST
HT News Desk, New Delhi
Gaganyaan mission: PM Modi announces names of 4 astronauts, netizens react
PM bestowed astronaut wings to the astronauts selected for ISRO’s Gaganyaan mission. A video of the ceremony was also shared on Instagram.
Updated on Feb 27, 2024 03:02 PM IST
Trisha Sengupta
NASA shares an interesting puzzle with a cat emoji as a hint. Can you solve it?
Brain Teaser: Do you think you can solve this Hubble-related quiz by NASA?
Published on Feb 23, 2024 07:01 AM IST
Trisha Sengupta
Sharad Pawar proposes Bharat Ratna for Dr Ponawalla
Dr Poonawalla, the chairman and managing director of SII, on Wednesday, was conferred with the late Dr Mohan Dharia ‘Rashtra Nirman Puraskar’ for the year 2024
Updated on Feb 15, 2024 04:34 PM IST
Vicky Pathare
Serum Institute's Adar Poonawalla invited to Ram Temple consecration: 'Humbled'
The industrialists who received the invitation include businessman Mukesh Ambani, Anil Ratan Tata, Gautam Adani, TS Kalyanaraman and the like.
Published on Jan 19, 2024 02:57 PM IST
Why rich Indians are buying marquee properties in London
Ultra-high net-worth individuals exploring the UK as an investment destination often have great cultural comfort and familiarity with the place.
Published on Dec 18, 2023 11:09 AM IST
Adar Poonawalla strikes a deal to buy London’s most expensive house of the year
Adar Poonawalla has agreed to pay the amount for a 25,000 square foot Mayfair mansion.
Updated on Dec 12, 2023 10:36 PM IST
Pune-based Serum Institute to soon start Phase I & II trials of dengue vaccine in India
The Phase 1 and Phase 2 study of Dengusiil in India will be conducted on 45 adults of 18 years and above and 75 children of 2 years of age and above and less than (<) 18 years of age
Updated on Nov 27, 2023 05:08 AM IST
Vicky Pathare
Serum Institute founder Cyrus Poonawalla suffers cardiac arrest, undergoes angioplasty
Cyrus Poonawalla, chairman of Serum Institute of India, suffered a mild cardiac arrest and underwent angioplasty. He is recovering and will be discharged soon.
Updated on Nov 17, 2023 10:37 PM IST
Vicky Pathare
Serum’s Cervavac vaccine for cervical cancer now in pvt hosps
Cervavac vaccine to fight cervical cancer has been developed and manufactured by the Pune-based Serum Institute of India (SII)
Updated on Jul 18, 2023 12:54 AM IST
Vicky Pathare
SII’s multivalent meningococcal meningitis vaccine gets WHO prequalification
It is also the only vaccine that prevents meningitis caused by meningococcal group X, a pathogen increasingly implicated in meningitis outbreaks in Africa
Updated on Jul 12, 2023 06:01 PM IST
RIL tops list of Indian companies, Serum Institute first among unlisted: Report
The Top 10 companies in India hold ₹71.5 lakh crore, accounting for 37% of GDP. 7 of them are headquartered in Mumbai. Here is the list:
Published on Jun 20, 2023 05:58 PM IST
HC restrains 2 influencers from posting defamatory content against SII, Covishield
The Bombay High Court has restrained two social media influencers from posting defamatory content about Serum Institute of India, its CEO and their Covishield product in an interim application filed by SII in a defamation suit against the influencers. The court directed Yohan Tengra and Ambar Kori to remove the content from Twitter and YouTube. The SII claims the content posted by the duo about multiple deaths being due to the side effects of the vaccine was not only targeted at SII but also its CEO, and sought directions to Twitter and YouTube to take down defamatory content.
Updated on Jun 06, 2023 01:03 AM IST
Bombay HC restrains activists from posting defamatory content on SII, Covishield
The order was passed in an interim application filed by SII in a defamation suit seeking ₹100 crore in damages from social media influencers Yohan Tengra and Ambar Kori for allegedly posting objectionable content regarding Covishield
Updated on Jun 05, 2023 03:28 PM IST
ED attaches Zavaray Soli Poonawalla’s assets worth ₹41.64 crore in Worli
Enforcement Directorate seizes properties worth INR 41.64 crore belonging to Zavaray Soli Poonawalla and family over foreign exchange violation probe linked to Panama Papers.
Updated on May 09, 2023 12:50 AM IST
Abhishek Sharan, Mumbai
‘Fema violation’ case: ED seizes ₹41.64cr assets of Pune bizman
The agency alleged that Zavareh Soli Poonawalla and his family members were accused of misuse of the Liberalised Remittance Scheme under the provisions of the Foreign Exchange Management Act.
Updated on May 09, 2023 12:34 AM IST
HT Correspondent, New Delhi
UK Investment Min inaugurates British Trade office in Pune
According to a press release released by the British Deputy High Commission, India remains a priority market for the UK
Updated on Apr 28, 2023 11:29 PM IST